《藥物經(jīng)濟(jì)學(xué)與結(jié)果研究專家評(píng)論》(ISSN 1473-7167)提供有關(guān)藥物臨床使用和治療方法的成本效益和藥物經(jīng)濟(jì)學(xué)問(wèn)題的專家評(píng)論。涵蓋范圍包括藥物經(jīng)濟(jì)學(xué)和生活質(zhì)量研究，治療結(jié)果，循證醫(yī)學(xué)和成本效益研究。所有的文章都要經(jīng)過(guò)嚴(yán)格的同行評(píng)審。該雜志采用獨(dú)特的專家評(píng)論文章格式，提供了一個(gè)關(guān)鍵技術(shù)領(lǐng)域、研究或臨床實(shí)踐的當(dāng)前思想的完整概述，并輔以以下章節(jié):專家評(píng)論-對(duì)最有效或最有前途的策略的個(gè)人觀點(diǎn)五年展望——在一個(gè)現(xiàn)實(shí)的時(shí)間尺度內(nèi)對(duì)未來(lái)前景的清晰展望關(guān)鍵問(wèn)題-執(zhí)行摘要削減到作者最關(guān)鍵的觀點(diǎn)

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points